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The delta-5 and delta-6 desaturases (D5D and D6D), encoded by fatty acid desaturase 1
(FADS1) and 2 (FADS2) genes, respectively, are rate-limiting enzymes in the metabolism
of ω-3 and ω-6 fatty acids. The objective of this study was to identify genes inﬂuencing
variation in estimated D5D and D6D activities in plasma and erythrocytes in Alaskan Eski-
mos (n= 761) participating in the genetics of coronary artery disease in Alaska Natives
(GOCADAN) study. Desaturase activity was estimated by product: precursor ratio of
polyunsaturated fatty acids. We found evidence of linkage for estimated erythrocyte D5D
(eD5D) on chromosome 11q12-q13 (logarithm of odds score= 3.5).The conﬁdence interval
contains candidate genes FADS1, FADS2, 7-dehydrocholesterol reductase (DHCR7 ), and
carnitine palmitoyl transferase 1A, liver (CPT1A). Measured genotype analysis found asso-
ciation between CPT1A, FADS1, and FADS2 single-nucleotide polymorphisms (SNPs) and
estimated eD5D activity (p-values between 10−28 and 10−5). A Bayesian quantitative trait
nucleotide analysis showed that rs3019594 in CPT1A, rs174541 in FADS1, and rs174568
in FADS2 had posterior probabilities > 0.8, thereby demonstrating signiﬁcant statistical
support for a functional effect on eD5D activity. Highly signiﬁcant associations of FADS1,
FADS2, and CPT1A transcripts with their respective SNPs (p-values between 10−75 and
10−7) inMexicanAmericans of the SanAntonio FamilyHeart Study corroborated our results.
These ﬁndings strongly suggest a functional role for FADS1, FADS2, and CPT1A SNPs in
the variation in eD5D activity.
Keywords: essential fatty acids, single-nucleotide polymorphisms, bayesian quantitative trait nucleotide analysis
INTRODUCTION
Essential fatty acids are important constituents of all cell mem-
branes and inﬂuence both inﬂammatory and atherosclerotic
processes. The essential fatty acids cis-linoleic acid (LA;18: 2 ω-6)
and α-linolenic acid (ALA; 18:3 ω-3) are metabolized to arachi-
donic acid (AA; 20:4 ω-6) and eicosapentaenoic acid (EPA; 20:5
ω-3), respectively,by delta-5 (D5D) anddelta-6 (D6D)desaturases
(Das, 2007; Figure 1). Since most of the products of the arachi-
donic acid pathway have pro-inﬂammatory effects, increased D5D
and D6D activity in the ω-6 pathway may promote systemic
inﬂammation and increase the risk of atherosclerosis (Das, 2007;
Allayee et al., 2009; Martinelli et al., 2009). Conversely, increased
activities of these desaturases could stimulate the synthesis of
EPA (which has anti-inﬂammatory properties) from ALA, coun-
teracting the effects of AA synthesis. However, both EPA and
AA are synthesized at very low rates in vivo (Harris et al., 2009;
Mozaffarian et al., 2010).
Diet, metabolism, and genetic variation inﬂuence the fatty
acid composition of the plasma lipids and cell membranes. The
variation in plasma and dietary fatty acids, particularly polyun-
saturated fatty acids (PUFAs), has been shown to be under con-
siderable genetic inﬂuence (Cai et al., 2004; Tanaka et al., 2009;
Voruganti et al., 2010). Recent genome-wide association studies
(GWAS) have shown a strong association between PUFAs and
single-nucleotide polymorphisms (SNPs) in fatty acid desaturase
1 and 2 (FADS1 and FADS2) genes, which code for D5D and D6D,
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FIGURE 1 | Metabolism of essential fatty acids.
respectively (Tanaka et al., 2009). These associations have been fur-
ther conﬁrmed by candidate gene studies in various populations
(Schaeffer et al., 2006; Malerba et al., 2008; Martinelli et al., 2008;
Lattka et al., 2009, 2010; Rzehak et al., 2009; Bokor et al., 2010;
Glaser et al., 2010; Mathias et al., 2010; Merino et al., 2011). In
addition, these GWAS have found association between FADS1
and FADS2 SNPs and cardiovascular disease (CVD) risk factors
(Tanaka et al., 2009). Both genes are located on chromosome
11q12-q13.1. Genome-wide linkage and association studies have
been conducted with plasma fatty acids (Schaeffer et al., 2006;
Malerba et al., 2008; Martinelli et al., 2008; Lattka et al., 2009,
2010; Rzehak et al., 2009; Bokor et al., 2010; Glaser et al., 2010;
Mathias et al., 2010; Voruganti et al., 2010; Merino et al., 2011),
but few studies have investigated genetic inﬂuences on estimated
desaturase activities in blood (Martinelli et al., 2008; Bokor et al.,
2010; Mathias et al., 2010; Merino et al., 2011).
Westernized diets are characterized by higher amounts of ω-6
PUFA more inclined to promote pro-inﬂammatory activities in
contrast to ω-3 PUFA (Allayee et al., 2009; Martinelli et al., 2009).
The Alaskan Eskimo population, which is transitioning away from
an ω-3 fatty acid-rich diet to a relatively westernized diet, is thus
at a higher risk for systemic inﬂammation and atherosclerosis.
Given these facts and the importance of D5D and D6D in essen-
tial fatty acid metabolism and inﬂammation, we investigated the
genetic inﬂuence on estimated D5D and D6D desaturase activ-
ities. Herein we present the results of a genome-wide scan and
candidate SNP analyses for estimated D5D and D6D activities in
Alaskan Eskimos participating in the genetics of coronary artery
disease in Alaska Natives (GOCADAN) study.
MATERIALS AND METHODS
STUDY DESIGN
In the GOCADAN study, 1214 individuals (all 18 years of age and
older) were recruited from villages in the Norton Sound region on
the northwestern coast of Alaska. Details of the study recruitment,
design, and methods have been reported by Howard et al. (2005);
Ebbesson et al. (2006). The Institutional Review Boards from
all participating institutions approved this study and informed
consent was obtained from all participants.
DEMOGRAPHIC AND PHENOTYPIC DATA
Demographic and genealogical data collected during the inter-
views includedname,gender,date andplace of birth, current home
of theparticipant andhis or her spouse,andﬁrst-degree relatives of
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all household members. Anthropometric measurements, height,
weight, and waist and hip circumference, were measured by stan-
dardized procedures. Body mass index (BMI) was calculated by
dividing weight (kilograms) by height (meters) squared. Body fat
was measured using a Quantum II bioelectrical body composition
analyzer (RJL Systems,ClintonTownship,MI). Triglycerides,high-
density lipoprotein (HDL), low-density lipoprotein (LDL), and
total cholesterol were measured using an auto analyzer (Hitachi
717, Amposta, Spain). Heart rate was measured via computerized
ECG (electrocardiograph; GE Systems MAC 1200), with the par-
ticipant at rest. Heart rate was calculated using the mean interval
between QRS complexes during a 10-s period. Apolipoprotein A1
(ApoA1) was analyzed by immunoprecipitation assay.
Of the 1214 individuals participating in the study, fatty acid
concentrations and desaturases data were available for 761 indi-
viduals (>35 years of age). Total plasma and erythrocyte fatty acid
concentrations were estimated following the methods previously
described by Ebbesson et al. (1999) and Ebbesson et al. (2010),
respectively. In short, analysis of the composition of fatty acids
was performed on a Hewlett Packard 5890 gas chromatograph
equipped with a 60m× 0.25mm SP330 capillary column chem-
ically bonded with 0.25μm liquid phase and a ﬂame ionization
detector. Structural conﬁrmation was determined by mass spec-
trometry using a Varian 2000 ion trap detector. Each fatty acid
measure was computed using a regression equation in which the
ratio of the area of each fatty acid peak to the internal standard was
plotted against the weight ratio of the fatty acid and the internal
standard. All fatty acids are expressed as percentages (mol/100ml
of total fatty acids).
Desaturases in plasma and erythrocytes were estimated by
product-precursor ratio of PUFAs (Warensjö et al., 2008).
D5D= [(20:4 ω-6)/(20:3 ω-6)]
D6D= [(18:3 ω-6)/(18:2 ω-6)]
GENOTYPE DATA
For each of the participants, 400 short tandem repeat (STR) mark-
ers (spaced at an average interval of 10 cMthroughout the genome)
were ampliﬁed from genomic DNA in separate polymerase chain
reactions (PCR) using ﬂuorescently labeled primer pairs (ABI
PRISM Linkage Mapping Set MD 10 Version 2, Applied Biosys-
tems, Foster City, CA, USA). Pedigree and Mendelian errors were
detected and corrected utilizing the software pedigree relationship
statistical tests (PREST) and SIMWALK (Sobel and Lange, 1996).
Multipoint identity-by-descent (IBD) matrices for genome-wide
linkage analyses were calculated using the linkage analysis package
LOKI (Heath, 1997). The chromosomal map (Haldane) used in
these computations was based on marker locations reported by
DeCode genetics (Kong et al., 2002).
SNP SELECTION AND GENOTYPING
We genotyped 324 SNPs clustered in the candidate genes within
the one-logarithm of odds (LOD) support interval of our quan-
titative trait locus (QTL) region (26 in FADS1, 100 in FADS2,
149 in carnitine palmitoyl transferase 1A, liver (CPT1A), and 49
in 7-dehydrocholesterol reductase (DHCR7 )). These SNPs were
selected to be within 2 kb upstream to 1 kb downstream of each
gene and were previously reported to be polymorphic in both
Asian and European populations. Of the 324 SNPs included in
data collection, 34 failed and 78 were not polymorphic in our
study population, leaving 212 polymorphic markers for analy-
sis (FADS1 = 16, FADS2 = 68, DHCR7 = 30, and CPT1A = 98).
SNPs were typed using the multiplex VeraCode technology from
Illumina according to the manufacturer’s protocol (Illumina, San
Diego, CA, USA).
Details of the technology are given in Voruganti et al. (2010).
Brieﬂy, the technology is based on allele-speciﬁc primer exten-
sion. Genomic DNA (250 ng) was chemically activated, labeled
with biotin, and then hybridized to a pool of locus-speciﬁc oligos.
After primer extension and ligation, a PCR reactionwas performed
using a ﬂurorescent-labeled primers, followed by hybridization to
VeraCode beads. The beads were then scanned on a BeadXpress
reader using theVeraScan software (Illumina).Genotype callswere
generated by analyzing the raw data using the software BeadStudio
(Illumina).
STATISTICAL ANALYSES
Univariate genetic analysis
A variance components decomposition method was used to esti-
mate heritability and detect linkage to chromosomal locations
affecting variation in estimated plasma and erythrocyte desat-
urase activities via genome-wide linkage analysis. This method
was implemented in the software program SOLAR and has been
described in detail elsewhere (Blangero and Almasy, 1997; Almasy
and Blangero, 1998). Before conducting genetic analyses, distrib-
utional properties of all traits were evaluated. All values greater
than four standard deviations from the mean were removed and
the remaining traits were transformed by inverse normalization
to meet assumptions of normality. All analyses were conducted
adjusting for age, sex, diabetes status, and use of lipid-lowering
medication.
Measured genotype analysis (MGA)
Genotype frequencies for each SNP were calculated using a
maximum-likelihood estimation method and were tested for
departures from Hardy–Weinberg equilibrium. Estimates of link-
age disequilibrium (LD) between SNPs were determined by calcu-
lating pair-wise D′ and r2 statistics. As a ﬁrst step in investigating
the association between the SNPs in candidate genes and varia-
tion in estimated desaturase activities, we employed MGA imple-
mented in SOLAR(Boerwinkle et al., 1986). This approach extends
the classical variance components-based biometrical model to
account for both the random effects of kinship and the main
effects of SNP genotypes. For each SNP, we compared this satu-
rated model with a null model in which the main effect of the SNP
is constrained to zero. The test statistic, twice the difference in loge
(likelihood) between the saturated model and the SNP-speciﬁc
null, has a chi-square distribution with one degree of freedom.
Bayesian quantitative trait nucleotide analysis
Themeasured genotype analysis described abovewasused to assess
association between the trait and each SNP, analyzing one SNP at a
time. However, multiple functional variants will often exist within
a chromosomal locus, and joint analysis of multiple variants may
be more powerful to detect their effects and to establish which of
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the many polymorphisms within a region are the most likely to be
functional. Blangero et al. (2005) developed the Bayesian quan-
titative trait nucleotide (BQTN) approach, which is essentially
a Bayesian method based on an underlying measured genotype
model that permits joint analysis of multiple variants. The BQTN
analysis was implemented in SOLAR to identify the functional
SNPs that are statisticallymost likely to be associatedwith a pheno-
type. Thismethodhas beendescribed indetail elsewhere (Blangero
et al., 2005).
Conditional linkage analysis
Linkage analysis (Sun et al., 2002) for estimated erythrocyte D5D
was performed conditional on SNPs that showed statistical evi-
dence of functionality. If the SNP or SNPs account for the linkage
signal completely, the LOD score will be reduced to zero.
SNP GENOTYPING AND IDENTIFICATION AND ANALYSIS OF
EXPRESSION TRANSCRIPTS IN MEXICAN AMERICANS
The SNPs selected for replication were part of the GWAS con-
ducted in the San Antonio Family Heart Study (SAFHS). The
SAFHS,a study initiated in 1991, focuses on identifying genetic and
environmental risk factors forCVD inMexicanAmericanswithout
regard to disease status. GWAS was conducted with SNPs obtained
using Illumina HumanHap550 genotyping BeadChip (Illumina
Inc., San Diego, CA). Lymphocyte expression data were available
for 1240 individuals participating in the SAFHS. However, data
on both transcripts and SNPs were available for 1189 individuals.
Details of identiﬁcation and analysis of transcripts are given in
Göring et al. (2007). Measured genotype analysis was conducted
to analyze the association of FADS1,FADS2, and CPT1A SNPs and
their cis-regulated transcripts and CVD-related traits in Mexican
Americans.
RESULTS
ESTIMATION OF HERITABILITY AND LOCALIZATION OF QTLs
Erythrocyte and plasma D5D and D6D activities were signiﬁ-
cantly heritable (Table 1), with values ranging between 0.50 and
0.90. Genome-wide linkage scans for D5D and D6D revealed a
QTL with strong linkage on chromosome 11 for estimated ery-
throcyte D5D (Figure 1). This QTL was localized to chromosome
11q12-q13 near marker D11S987 with a LOD score of 3.5 (Table 1,
Figure 2). The one-LOD support interval for this QTL spanned
approximately 20 cM between markers D11S4191 and D11S1314.
This interval contains promising candidate genes including the
FADS1 gene that codes for D5D. Other candidate genes in this
interval are FADS2, DHCR7, and CPT1A.
MEASURED GENOTYPE ANALYSIS
Linkage disequilibrium patterns of these SNPs are shown in
Figure S1 in Supplementary Material. All of the SNPs were tested
for association with estimated erythrocyte and plasma D5D and
D6D and their individual components. Polymorphisms in FADS1,
FADS2, and CPT1A showed strong association with erythrocyte
and plasma D5D and D6D (Figure 3). Estimated erythrocyte D5D
and its components 20:3 ω-6 and 20:4 ω-6 showed the strongest
association, with p-values ranging from 10−28 to 10−5 (Table 2).
Similarly, estimated plasma D5D and its components, used to esti-
mate the ratio, showed signiﬁcant associations with SNPs in the
three genes (p-values 10−39 to 10−16). However, the association of
plasma 20:3ω-6with these SNPswas not signiﬁcant after adjusting
for multiple testing. For estimated plasma D6D, only the associ-
ation with SNPs in the FADS1 and FADS2 genes was signiﬁcant,
whereas associationwith erythrocyteD6Dwas signiﬁcant for SNPs
in all three genes (Table 3). Detailed results of the association with
estimated plasma and erythrocyte D5D and D6D activities and
their individual components are shown in Tables S1 and S2 in
Supplementary Material.
These SNPs were also tested for their association with cardio-
vascular risk factors, heart rate, plaque, triglycerides, HDL, LDL,
and total cholesterol. SNPs in all three genes were associated with
heart rate and HDL cholesterol (Table 4). However, after adjusting
for multiple testing, only the association with heart rate remained
signiﬁcant. Individuals with minor alleles of these genes had a
lower heart rate.
BQTN ANALYSIS
Because BQTN analysis is designed to identify SNPs that are most
likely to have a functional effect on a trait and it is robust to mul-
tiple testing, (Boerwinkle et al., 1986) the SNPs were next tested
by BQTN analysis. In the current analyses, SNPs were utilized
after removing SNPs that were in LD (>90%) with other SNPs.
One variant from each gene showed a posterior probability greater
than 0.8. SNPs rs174541 from FADS1 and rs174568 from FADS2
showed posterior probabilities of 1, indicating a strong probability
of having a functional effect on erythrocyte D5D. However, with
plasmaD5D, rs3019594 of CPT1A was the only SNP to show a pos-
terior probability of 1. The genotype-speciﬁc phenotype means
show minor alleles of all three SNPs to be associated with higher
Table 1 | Heritabilities and linkage results for D5D and D6D*.
Trait Mean (SD) h2 (SE) p-Value Chr Location (cM) LOD score
PLASMA
D5D 0.683 (0.30) 0.502 (0.15) 0.00036 3 97 1.615
D6D 0.0187 (0.01) 0.897 (0.22) 0.000275 2 174 1.569
ERYTHROCYTE
D5D 8.015 (2.6) 0.544 (0.11) 0.0000003 11 82 3.53
D6D 0.0069 (0.003) 0.649 (0.12) 7.4×10−9 2 35 1.43
*Age, sex, diabetes status, and lipid medication were used as covariates.
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levels of erythrocyte and plasma D5D (Table 5). None of these
SNPs showed posterior probabilities greater than 0.5 for estimated
plasma or erythrocyte D6D activities.
CONDITIONAL LINKAGE
A linkage scan conditional on the three SNPs, which showed pos-
terior probability of 0.8 and greater, decreased the LOD score for
erythrocyte D5D signiﬁcantly from 3.5 to 1.5 for CPT1A SNP and
1.9 for FADS1 and FADS2 SNPs (Figure 4).
EXAMINATION OF CIS -REGULATED FADS1, FADS2, AND CPT1A
TRANSCRIPTS IN MEXICAN AMERICANS
In a previous study by Göring et al. (2007), linkage analysis was
conducted to identify genetic factors that affect the variation in
FIGURE 2 | Genome-wide linkage analysis for erythrocyte D5D
localizes a QTL on chromosome 11.The QTL for plasma and erythrocyte
D5D estimates on chromosome 11. Solid line, erythrocyte D5D (LOD=3.5
at 82 cM); dashed line, plasma D5D (LOD=0.9 at 81 cM).
the levels of gene expression. The study identiﬁed a number of
known cis-regulated transcripts with high-magnitude LOD scores.
Included among these, FADS1, FADS2, and CPT1A transcript
levels were found to be strongly associated with SNPs located
nearby (cis) their coding locus, with p-values ranging from 10−75
to 10−7. Just as in the GOCADAN study, these SNPs were also
tested for their association with cardiovascular risk factors, heart
rate, plaque, triglycerides, HDL, LDL, and total cholesterol in
the SAFHS, a large family-based study of genetics of coronary
artery disease in Mexican Americans. Nominal associations were
obtained between the SNPs and ApoA1, and HDL, LDL, total
cholesterol and heart rate in the SAFHS (Table 6).
DISCUSSION
The key ﬁnding of this study is the strong statistical support for
functional effects of FADS1, FADS2, and CPT1A SNPs on the vari-
ation in estimated erythrocyte and plasma D5D, a rate-limiting
enzyme in the conversion of essential fatty acids to AA (20:4 ω-
6) and EPA (20; 5 ω-3). High heritability estimates for estimated
plasma and erythrocyte D5D and D6D activities observed in this
study show that there is a signiﬁcant genetic inﬂuence on their
variation. Although no study has so far computed heritabilities for
desaturase activities, heritabilities of their individual components
have been estimated and have been found to be lower than our
desaturase estimates (Tanaka et al., 2009; Voruganti et al., 2010).
Similarly, no linkage studies have been conducted for estimated
desaturase activities. A genome-wide scan conducted for plasma
and erythrocyte D5D and D6D activities in the current study
showed evidence of a highly signiﬁcant QTL on chromosome
11q12-q13 for estimated erythrocyte D5D. This region has four
potential candidate genes, FADS1, FADS2, CPT1A, and DHCR7.
To follow up on our QTL,we genotyped SNPs in the four potential
candidate genes and conducted measured genotype-based associ-
ation analyses with estimated plasma and erythrocyte D5D and
D6D. Desaturases are key enzymes facilitating the introduction
of double bonds between carbon atoms of fatty acyl chains in
FIGURE 3 | Manhattan plots showing the association of SNPs on CPT1A and FADS1 and FADS2 with erythrocyte D5D. (A) CPT1A and (B) FADS1and
FADS2.
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Table 2 | Measured genotype association results for SNPs most significantly associated with D5D.
Gene SNP Minor allele (frequency) MGA (p-value)*
RBC Plasma
20:4 ω−6 20:3 ω−6 D5D 20:4 ω−6 20:3 ω−6 D5D
FADS1 rs174541 A (0.113) 2.2×10−26 1.8×10−5 8.1×10−28 1.2×10−28 8.8×10−3 8.5×10−16
rs174546 G (0.114) 1.5×10−24 2.7×10−5 4.3×10−26 3.6×10−28 0.009 2.4×10−15
rs174556 G (0.122) 2.2×10−26 1.1×10−26 8.1×10−28 1.3×10−28 0.009 8.9×10−16
FADS2 rs1535 A (0.116) 1.9×10−25 1.5×10−5 2.5×10−27 2.3×10−29 0.012 2.8×10−16
rs174568 G (0.115) 1.1×10−25 9.5×10−6 2.2×10−27 7.7×10−30 0.040 1.7×10−24
rs174570 G (0.161) 1.3×10−28 0.009 8.2×10−21 1.4×10−34 0.015 1.2×10−19
rs174576 C (0.116) 7.1×10−25 8.5×10−6 5.1×10−27 2.0×10−28 0.012 2.3×10−16
rs174579 G (0.426) 0.0004 9.9×10−7 1.9×10−11 6.1×10−9 0.866 5.7×10−6
rs968567 A (0.038) 0.096 0.0003 0.032 0.023 0.625 0.042
CPT1A rs11228368 G (0.138) 2.0×10−13 0.0004 5.2×10−16 3.3×10−23 0.157 1.6×10−16
rs3019594 A (0.217) 2.2×10−27 1.1×10−5 1.3×10−27 6.6×10−39 0.040 1.7×10−24
rs613084 A (0.065) 7.2×10−13 0.054 1.6×10−9 3.2×10−11 0.037 2.1×10−7
*p-Values <0.0002 are considered signiﬁcant after adjusting for multiple testing. These are depicted in bold.
Table 3 | Measured genotype association results for SNPs with D6D.
Gene SNP MGA (p-value)*
RBC Plasma
18:3 ω−6 18:2 ω−6 D6D 18:3 ω−6 18:2 ω−6 D6D
FADS1 rs174541 0.00017 2.3×10−9 1.1×10−12 0.003 0.003 2.6×10−5
rs174546 0.0005 1.3×10−9 4.8×10−12 0.004 0.0008 4.8×10−5
rs174556 0.00016 6.8×10−9 2.0×10−12 0.005 0.0016 4.0×10−5
FADS2 rs1535 0.00029 2.1×10−9 3.1×10−12 0.003 0.0018 2.6×10−5
rs174568 2.7×10−4 2.4×10−9 3.1×10−12 0.003 0.002 2.6×10−5
rs174570 0.0033 2.8×10−11 6.1×10−11 0.056 0.002 0.0010
rs174576 0.00033 2.2×10−9 4.3×10−12 0.003 0.0007 2.6×10−5
rs174579 0.232 0.0028 0.932 0.960 0.171 0.239
rs968567 0.497 0.039 0.747 0.051 0.577 0.233
CPT1A rs11228368 0.221 3.8×10−6 0.423 0.860 0.009 0.181
rs3019594 0.469 5.4×10−12 0.012 0.560 0.0015 0.043
rs613084 0.119 8.2×10−6 6.7×10−5 0.881 0.086 0.301
*p-Values <0.0002 are considered signiﬁcant after adjusting for multiple testing. These are depicted in bold.
the metabolism of dietary PUFAs (Martinelli et al., 2009). Given
the dependence of pro- or anti-inﬂammatory eicosanoid for-
mation on the availability of ω-3 or ω-6 PUFAs, the form of
dietary PUFA consumed is critical. In our study group, dietary
ω-3 and ω-6 PUFA were found to positively associated with age,
with younger individuals consuming more of saturated fatty acid-
rich foods indicating a shift away from traditional foods rich in
ω-3 FAs.
In the current study, a strong association between the SNPs and
estimated plasma and erythrocyte D5D activities was observed. In
particular, minor alleles of FADS1, FADS2, and CPT1A SNPs were
associated with higher desaturase activity. Few studies have been
conducted to examine the association of FADS1 and FADS2 SNPs
with estimated desaturase activities. Polymorphisms in the FADS
cluster have been found to be signiﬁcantly associated with serum
estimated D5D and D6D activities in European adolescents and
adults froman islandpopulationof Europeandescent (Bokor et al.,
2010; Mathias et al., 2010). In contrast to our study, they found
minor alleles in FADS1 and FADS2 genes to be associated with
lower D5D activities. In another study, Martinelli et al. (2008)
found FADS haplotypes to be associated with higher estimated
erythrocyte desaturase activity. Similarly in a study conducted in
Caucasian and Asian adults FADS1 and FADS2 SNPs were associ-
ated with altered desaturase activity (Merino et al., 2011). On the
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Table 4 | Measured genotype association (MGA) results for SNPs with CVD-related phenotypes.
Gene SNP MGA (p-value)*
ApoA1 Total cholesterol Triglycerides HDL LDL Heart rate Plaque
FADS1 rs174541 0.010 0.623 0.120 0.0003 0.672 2.9×10−5 0.808
rs174546 0.011 0.685 0.192 0.00057 0.565 1.9×10−5 0.856
rs174556 0.003 0.455 0.095 9.0×10−5 0.794 1.6×10−5 0.775
FADS2 rs1535 0.015 0.646 0.128 0.00047 0.665 1.0×10−5 0.664
rs174568 0.016 0.697 0.127 0.0006 0.653 8.5×10−6 0.708
rs174570 0.011 0.119 0.234 0.001 0.484 6.1×10−8 0.213
rs174576 0.010 0.679 0.114 0.00037 0.598 6.9×10−6 0.679
rs174579 0.249 0.930 0.508 0.097 0.149 0.0066 0.329
rs968567 0.510 0.155 0.900 0.969 0.094 0.0063 0.143
CPT1A rs11228368 0.026 0.289 0.439 0.057 0.780 8.6×10−8 0.056
rs3019594 0.001 0.088 0.794 0.001 0.729 2.8×10−10 0.206
rs613084 0.001 0.177 0.997 7.1×10−5 0.670 0.0009 0.817
*p-Values <0.0002 are considered signiﬁcant after adjusting for multiple testing. These are depicted in bold.
Table 5 | Bayesian quantitative trait nucleotide analysis for erythrocyte and plasma D5D.
Gene SNP Location in the gene Mean effect size Posterior probability of a functional effect AAa ABa BBa
ERYTHROCYTE
FADS1 rs174541 Flanking 3′ UTR 0.168 1 7.65 (2.4)b 9.73 (2.1) 13.56 (3.1)
FADS2 rs174568 Flanking 3′ UTR 0.171 1 7.65 (2.4) 9.75 (2.1) 13.56 (3.1)
CPT1A rs3019594 Intron 0.172 0.8 7.49 (2.2) 8.85 (2.4) 12.40 (3.1)
PLASMA
FADS1 rs174541 Flanking 3′ UTR 0.168 0.5 0.63 (0.3) 0.85 (0.3) 1.47 (0.3)
FADS2 rs174568 Flanking 3′ UTR 0.174 0.6 0.63 (0.3) 0.86 (0.3) 1.47 (0.3)
CPT1A rs3019594 Intron 0.261 1 0.60 (0.3) 0.81 (0.3) 1.19 (0.3)
aA, major allele; B, minor allele.
bMean (standard deviation).
other hand, several population studies have reported associations
of FADS SNPs with PUFAs. In the ﬁrst of a series of studies,FADS1
and FADS2 SNPs were associated with fatty acids in phospholipids
in Europeans and accounted for about 28% of the variance in fatty
acids (Schaeffer et al., 2006). Minor alleles of these genotypes were
associated with higher levels of LA18: 2 ω-6 and ALA18: 3 ω-3
and lower levels of AA 20:4 ω-6 and EPA 20:5 ω-3. This study was
replicated by Rzehak et al. (2009) in a Bavarian population of Ger-
many. In addition to phospholipids, this study also demonstrated
an association between FADS1 and FADS2 SNPs and erythrocyte
membrane PUFAs. Similarly,PUFAs in erythrocytes and phospho-
lipids were associated with FADS1 and FADS2 SNPs in an Italian
population (Malerba et al., 2008). In these studies, minor alleles
were associated with higherALA levels (Martinelli et al., 2008) and
lower levels of AA (Malerba et al., 2008) in accordance with Scha-
effer et al. (2006). However, in our study, minor alleles of all three
genes were associated with increased plasma and erythrocyte AA
20:4 ω-6 levels and reduced EPA 20:5 ω-3 levels. The differences
observed here may be attributed to the differences in population
structure, or LD patterns of the SNPs based on population groups
and dietary patterns.
Genetic studies conducted with PUFAs so far have found asso-
ciations with SNPs on FADS1 and FADS2 but not those on CPT1A.
Studies on desaturases in humans are mostly based on desat-
urase activity estimates calculated from product:precursor fatty
acid ratios. Because most of the lipids in circulation in the fasting
state are derived from the liver, these desaturation indices calcu-
lated from fasting samples are thought to reﬂect hepatic desaturase
activity (Sjogren et al., 2008; Merino et al., 2010). Thus, the role
of liver-speciﬁc CPT1A enzyme in the regulation of liver-speciﬁc
desaturases, in addition to PUFAs, assumes signiﬁcance. This is
supported by our results, which show strong association of CPT1A
SNPs with estimated plasma and erythrocyte D5D activities.
The CPT1A gene is 60 kb long with 18 coding exons and is
known to be modulated by dietary and hormonal factors in tissues
such as heart,muscle, and liver (Gobin et al., 2002;Bonnefont et al.,
2004). CPT1A is a liver-speciﬁc outer-membrane enzyme that
plays a key role in the transport of PUFAs across themitochondrial
membrane and in β-oxidation. Unlike short- and medium-chain
fatty acids, PUFAs cannot be transported across the mitochondr-
ial membrane by simple diffusion. The PUFAs are ﬁrst converted
to their co-A esters and in combination with carnitines they are
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FIGURE 4 | Conditional linkage analysis for erythrocyte D5D on
chromosome 11. Linkage analysis conditional on the most signiﬁcantly
associated SNP in (A) CPT1A, (B) FADS1, and (C) FADS2. Solid line,
erythrocyte D5D; dashed line, erythrocyte D5D conditional on SNPs.
converted to acylcarnitines by CPT1A enzyme and transported
across the mitochondrial membrane (Prip-Buus et al., 2001). In a
study conducted in a Greenland Inuit population,Rajakumar et al.
(2009) found that variant P479L of CPT1A was very common and
was associated with higher levels of HDL and ApoA1 and thus
may be protective against atherosclerosis. In a study in Canadians,
CPT1A and CPT1B variants were associated with obesity traits.
In addition, the investigators found that the dietary intake of fat
seemed to modulate these associations, particularly in individu-
als who were consuming high-fat diets (Robitaille et al., 2007).
In another study, haplotypes of CPT1A were associated with left
ventricular mass in essential hypertension (Tripodi et al., 2005). In
the current study, the minor alleles of all three genes were associ-
ated positively with all CVD risk factors and with both desaturase
activity estimates.
The BQTN analysis helps narrow down the variants for fur-
ther molecular and functional analyses by identifying which SNP
has the highest probability of being associated with the pheno-
type. Our BQTN ﬁndings demonstrate with a strong statistical
support that SNPs in FADS1,FADS2, and CPT1A genes have either
a functional role or they are in high LD with functional variants
affecting D5D activities. In addition, the high genetic variance
(17–26%) for D5D activities explained by these SNPs show the
importance of FADS1, FADS2, and CPT1A gene polymorphisms
in the activity of D5D. Furthermore, a linkage analysis condi-
tional on the three SNPs resulted in approximately 60% decrease
in the LOD score, indicating that the SNPs accounted for a sub-
stantial part of the QTL but did not explain the linkage signal
completely.
In an effort to glean further support for the association,we con-
ducted association analyses of cis-regulated transcripts of FADS1,
FADS2, and CPT1A genes with their respective SNPs in Mexican
Americans. cis-regulated transcripts are deﬁned as transcripts that
contain genetic variation within their gene and regulatory regions
that affect their abundance (Göring et al., 2007). We found highly
signiﬁcant association of FADS1, FADS2, and CPT1A transcripts
with their respective SNPs. These ﬁndings in Mexican Ameri-
cans support our plasma and erythrocyte D5D associations in
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Table 6 | Measured genotype association results for SNPs with CVD-related phenotypes and cis-regulated transcripts in Mexican Americans.
Gene SNP MGA (p-value)*
Transcripts APOA1 Total cholesterol Triglycerides HDL LDL Heart rate Plaque
FADS1 rs174546 1.23×10−31 0.055 0.044 0.730 0.058 0.163 0.039 0.518
rs174556 2.53×10−32 0.094 0.038 0.700 0.090 0.154 0.101 0.619
FADS2 rs1535 1.89×10−29 0.081 0.069 0.763 0.072 0.241 0.114 0.304
rs174570 3.42×10−7 0.168 0.772 0.710 0.282 0.709 0.041 0.461
rs174576 4.45×10−29 0.053 0.041 0.727 0.034 0.184 0.080 0.514
rs174579 3.13×10−24 0.316 0.580 0.649 0.406 0.467 0.943 0.394
rs968567 2.57×10−75 0.933 0.034 0.333 0.518 0.032 0.370 0.882
CPT1A rs11228368 2.43×10−22 0.133 0.506 0.970 0.186 0.306 0.632 0.798
rs613084 1.14×10−62 0.281 0.883 0.771 0.234 0.336 0.587 0.821
*p-Values <0.006 are considered signiﬁcant after adjusting for multiple testing. These are depicted in bold.
Alaskan Eskimos, indicating strong support for a signiﬁcant role
of FADS1, FADS2, and CPT1A SNPs in D5D activity. Lack of fatty
acid data in the Mexican American population limits our abil-
ity to analyze the association of D5D in plasma or erythrocytes
for replication purposes but the transcript data provides valu-
able insight into the role of variants in the regulation of D5D.
Another limitation of this study is using estimated indices from
individual fatty acids as surrogate measure of desaturase activities.
However, studies conducted with desaturases have used product:
precursor fatty acids ratio as an estimate or a surrogate measure
of desaturase activity (Martinelli et al., 2008; Bokor et al., 2010;
Merino et al., 2011), and are now well accepted given the difﬁ-
culties measuring in vivo activities of these enzymes in humans.
In addition, we were also able to obtain strong association of
SNPs in FADS1, FADS2, and CPT1A with individual fatty acid
components.
In summary, we report for the ﬁrst time the association of
liver-speciﬁc CPT1A SNPs with liver-speciﬁc desaturases with
a strong statistical support for functional effects. In addition,
we replicate the association of FADS1 and FADS2 SNPs with
desaturase activities and PUFAs in Alaskan Eskimos.
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